Human dental follicle cells (DFCs) derived from wisdom teeth are precursor cells for cementoblasts. In this study, we recognized that naïve DFCs express constitutively the early neural cell marker b-IIItubulin. Interestingly, DFCs formed b-III-tubulin-positive neurosphere-like cell clusters (NLCCs) on lowattachment cell culture dishes in serum-replacement medium (SRM). For a detailed examination of the neural differentiation potential, DFCs were cultivated in different compositions of SRM containing supplements such as N2, B27, G5 and the neural stem cell supplement. Moreover, these cell culture media were combined with different cell culture substrates such as gelatin, laminin, poly-L-ornithine or poly-L-lysine. After cultivation in SRM, DFCs differentiated into cells with small cell bodies and long cellular extrusions. The expression of nestin, b-III-tubulin, neuron-specific enolase (NSE) and neurofilament was up-regulated in SRM supplemented with G5, a cell culture supplement for glial cells, and the neural stem cell supplement. DFCs formed NLCCs and demonstrated an increased gene expression of neural cell markers b-III-tubulin, NSE, nestin and for small neuron markers such as neuropeptides galanin (GAL) and tachykinin (TAC1) after cultivation on poly-L-lysine. For a further neural differentiation NLCC-derived cells were sub-cultivated on laminin and poly-L-ornithine cell culture substrate. After 2 weeks of differentiation, DFCs exposed neural-like cell morphology with small neurite-like cell extrusions. These cells differentially express neurofilament and NSE, but only low levels of b-III-tubulin and nestin. In conclusion, we demonstrated the differentiation of human DFCs into neuron-like cells after a two-step strategy for neuronal differentiation.
Introduction
Although the use of human embryonic stem cells poses multiple options for cell therapies of neural diseases, the development of therapeutic replacement strategies using adult stem cells remains a realistic alternative. Neural differentiation of bone marrow-derived mesenchymal stem cells was evaluated in various previous studies Corti et al., 2004) . Here a rather wide range of chemicals, growth factors and cell culture substrates have been used in efforts to initiate neural differentiation of mesenchymal stem cells with varying success Corti et al., 2003; Hemptinne et al., 2004; Hermann et al., 2004 Hermann et al., , 2006 Ho et al., 2006; Krabbe et al., 2005) . Dental stem cells are related to bone marrow-derived mesenchymal stem cells but they are less well characterized for neural differentiation . Dental cells are nonetheless easily accessible and therefore an interesting alternative for cell therapy approaches . Shi and coworkers isolated SHED (stem cells from human exfoliated deciduous teeth) that can differentiate into a variety of cell types, including neural cells (Miura et al., 2003) . Recently, neural stem cells could be isolated from dental tissues, which could be propagated as neurospheres under serum-free medium conditions supplemented with growth factors (Widera et al., 2007) . Today, the formation of neurospheres is the most common way of isolating and expanding neural stem cells in vitro . Isolated periodontal stem cells were highly proliferative (Widera et al., 2007) . Growth factor deprivation and retinoic acid treatment led to the acquisition of neural morphology and stable expression of markers of neural differentiation by more than 90% of the cells (Widera et al., 2007) . In contrast to these periodontalderived neural stem cells, dental pulp-derived stem cells or dental follicle cells (DFCs) are -like bone marrow-derived mesenchymal stem cells -plastic-adherent cells.
In our study we investigated neural differentiation potential of dental follicle cells, which were isolated from the ectomesenchymal 10.1016/j.diff.2009.03.002 dental follicle Morsczeck et al., 2005a, b) . Ectomesenchymal cells are derived from the neural crest, which also give rise to the peripheral nervous system . In this context, Pardal et al. (2007) recently discovered neural crest stem cells of the peripheral nervous system, which generated dopaminergic neurons in vivo. This fact makes very promising the use of ectomesenchymal cells for neural tissue cell therapies. In previous studies, we demonstrated that DFCs can differentiate into osteogenic cells under in vitro and in vivo conditions (Morsczeck et al., 2005a, b) . Recently, Kemoun et al. (2007) demonstrated that isolated dental follicle cells expressed the mesenchymal stem cell marker STRO-1. Moreover, they confirmed that follicle cells have multipotential mesenchymal precursor cell properties after differentiating toward multiple mesenchymal-derived cell types, such as cementoblasts, chondrocytes and adipocytes (Kemoun et al., 2007) . However, they did not demonstrate neural cell differentiation potential for dental follicle cells.
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The neural differentiation potential of DFCs under in vitro conditions was therefore evaluated for the first time. In this study, various cell culture media conditions were examined and compared in combination with different surface modifications for neurosphere-like cell cluster (NLCC) formation in DFCs. We investigated furthermore the expression of neural cell-specific cell markers in DFCs by immunocytochemistry and quantitative realtime RT-PCR. For a further neural differentiation, NLCCs were cultivated on poly-L-ornithine and laminin.
Materials and methods

Cell culture
Normal human impacted third molars were collected from adults (18 and 24 years). Coronal parts of the dental follicle were derived from unerupted or partially erupted wisdom teeth. The surfaces of these tissues were cleaned and minced by using a sterilized scalpel. Dental follicle precursor cells were isolated as described previously (Kemoun et al., 2007; Morsczeck et al., 2005a, b) . Dental follicle precursor cells were seeded into cell culture flasks in regular cell culture medium DMEM [Dubelco modified Eagle medium (with L-glutamine) supplemented with 10% fetal calf serum and penicillin/streptomycin (all purchased from PAA, Pasching, Austria] and incubated at 37 1Cin5%CO 2 in a humidified atmosphere.
For the induction of neural differentiation, various cell culture media were used. DFCs were used at passage 5 for experiments. Cell culture media were based on serum-replacement media (SRM) comprising Neurobasal medium (PAA) containing different supplements and growth factors. We tested different neural stem cell differentiation media (NSCM) protocols in our study. These protocols were combined with different cell substrates (see below). For neural differentiation protocol NSCM I DFCs were cultured in Neurobasal medium containing L-glutamine, the G5-supplement and neural stem cell supplement (all PAA) for one week. The G5 supplement contains 100 mg/ml biotin, 1 mg/ml EGF, 500 ng/ml FGF-2, 500 mg/ml human transferrin, 360 ng/ml hydrocortisone, 500 mg/ml insulin, 520 ng/ml sodium selenite.
For protocol NSCM II DFCs were cultivated in the Neurobasal medium containing L-glutamine, the B27 supplement (all PAA) in combination with growth factors (20 ng/ml EGF (Sigma-Aldrich, St. Louis, USA) and 20 ng/ml FGF-2 (Sigma-Aldrich)) for 4 days and without growth factors but with retinoic acid for additional 7 days. The B27 supplement were purchased from PAA and contains undisclosed concentrations of biotin, L-carnitine, cholesterol, corticosterone, ethanolamine, D(+)-galactose, glutathione (reduced), lecithin, linoleic acid, linolenic acid, phosphatidylcholin, progesterone, putrescine, retinol, retinyl acetate, sodium selenite, T3 (triodo-I-thyronine), DL-a-tocopherol (vitamin E), DL-a-tocopherol acetate, albumin, catalase, insulin, superoxide dismutase, and transferring. For NSCM III, cells were cultivated in Neurobasal medium supplemented with B27 and retinoic acid without growth factors for 7 days. DFCs were plated at a cell density of 25,000 cells/cm 2 for neural differentiation. Cell culture media were changed every second day.
For further neural differentiation, cells were incubated as follows. DFCs were cultivated in NSCM I on poly L-lysine to form neurosphere-like structures. These pre-differentiated DFCs were further differentiated by protocol NDSS: DMEM/F12 Media (PAA), Insulin-transferrin-sodium selenite supplement (ITTS, Roche, Mannheim, Germany), 100 U/ml penicillin and 100 mg/ml streptomycin, and 40 ng/ml FGF-2 for 14 days. The medium was supplemented with 0.5 mM retinoic acid (Sigma-Aldrich) between days 7 and 14 of differentiation. The surface was modified with poly-L-ornithine and laminin.
Preparation of culture substrates
The expansion and induction of neural differentiation under different cell culture conditions were performed in 6-well tissue grade polystyrene plates. The surfaces of wells were precoated with substrates of interest. The following concentrations were applied for surface modifications:
2 ). Substrates were purchased from Sigma-Aldrich and BD Biosciences (Heidelberg, Germany).
Immunocytochemistry
Fixed cells were washed in Tris-buffered saline (BS) (0.15 M NaCl, 0.1 M Tris-HCl, pH 7.5), then blocked with a solution composed of TBS, 0.1% Triton-X100 (only for intracellular antigens), 1% bovine serum albumin (BSA) and 0.2% Teleostean gelatin (Sigma-Aldrich) (fish gelatin buffer [FGB] ). The same solution was used during the incubations with antibodies. Primary antibodies were applied overnight at 4 1C. Fluorochrome-conjugated species-specific secondary antibodies were used for immunodetection.
The following antibodies and final dilutions were used. Primary antibodies: mouse anti-neuron-specific enolase (anti-NSE) (1:200; AbD serotec); rabbit anti-glial fibrillary acidic protein (GFAP) (1:1,000; Dako Denmark A/S, Glostrup); mouse anti-rat nestin (1:500; BD PharMingen, San Diego, USA); mouse anti-Map 2a+2b (1:250; Sigma-Aldrich); mouse anti-b-III-tubulin (1:500; clone 5G8; Promega, Madison, USA); mouse anti-(PAN) neurofilament medium and heavy (1:1000 Invitrogen, Karlsruhe, Germany); secondary antibodies: donkey anti-goat, -mouse, -rabbit or -rat conjugated with Alexa Fluor 488 (Invitrogen), goat anti-mouse, -rabbit or -rat conjugated with Alexa Fluor 488, RHOX (1:500). Nuclear counterstaining was performed with 4 0 ,6 0 -diamidino-2-phenylindole dihydrochloride hydrate (DAPI) at 0.25 mg/ml (Sigma-Aldrich). Specimens were mounted on microscope slides using a Prolong Antifade kit (Invitrogen). Epifluorescence observation and photodocumentation were accomplished using a Leica microscope. For negative controls, the primary antibodies were omitted.
Real-time reverse transcription (RT)-PCR
Total RNA was isolated from cells with the RNeasy Kit (Qiagen, Hilden, Germany). Genomic DNA contamination was eliminated with Rnase-free DNase for on-column digestion (Macherey-Nagel,
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F. Völlner et al. / Differentiation 77 (2009) 433-441 434 Dü ren, Germany). Total RNA from human total brain was derived from Clontech (Mountain View, USA). First-strand cDNA synthesis was performed by using 0.4 mg total RNA and the First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany). We used the TaqMan s Fast Universal PCR Master Mix (Applied Biosystems, Foster City, USA). Sequences for primers and probes were selected using the Universal ProbeLibrary Assay Design Center (www. roche-applied-science.com) and can be obtained from the authors. For quantification, we used the delta/delta calculation method described previously (Winer et al., 1999) . The housekeeping genes for GAPDH and GUS were used as reference genes in all applications. PCR primers were established with total RNA from the brain (Clontech, Mountain View, USA). For negative control the reverse transcriptase omitted in the first-strand synthesis kit (-RT, data not shown). PCR primers were established by using cDNAs made from commercial available total RNA from various human tissues (BD Bioscience, Franklin Lakes, NJ, USA).
Results
Gene expression of neural cell markers in naïve DFCs
DFCs were isolated and initially cultivated in regular cell culture medium. The growth curve demonstrated cell proliferation of DFCs at passage 6 ( Fig. 1 ). Before evaluation of neural cell differentiation, the expression of neural cell markers was investigated in naïve DFCs by immunocytochemistry. These cells express not only the neural progenitor cell marker nestin as previously described (Morsczeck et al., 2005a, b) but also neural cell makers, which represent different developmental stages. In immunocytochemical stainings, DFCs expressed the early neural cell marker b-III-tubulin (94%74.7 SEM), but late neural differentiation markers such as neurofilament and NSE were weakly expressed if at all ( Fig. 2A) . However, the glial cell marker GFAP was not detected in undifferentiated cells (data not shown).
Interestingly, DFCs formed nestin and b-III-tubulin-positive
neurosphere-like cell clusters after cultivation on lowattachment cell culture dishes. Here, cells were cultivated in serum-free cell culture medium containing the B27 supplement and EGF and FGF-2 (Fig. 2B) . The gene expression of neurofilament and b-III-tubulin was up-regulated in NLCCs (Fig. 2C ).
Pre-differentiation of DFCs (first step)
For a detailed analysis of the neural differentiation of DFCs we examined cell morphology, NLCC formation and gene expression of neural cell markers after applying different cell culture conditions (Figs. 3 and 4) . DFCs cultivated in regular cell culture medium (DMEM) expressed transcripts of nestin, b-III-tubulin, neurofilament, neuron-specific enolase and MAP-2 at all points in time of the study. DMEM-treated DFCs demonstrated a fibroblastic cell morphology on all tested cell culture surfaces (Fig. 3) and neural cell markers were almost constitutively expressed on all different surface modifications (Fig. 4) . However, gene expression of nestin was up-regulated on poly-Llysine (Fig. 4) . In contrast, the expression of neural cell markers was up-regulated in SRM; especially after cultivation in NSCM I (Fig. 4F) . Cell morphologies of DFCs in SRM varied with different substrate surface modifications. DFCs formed NLCCs on poly-Llysine with each tested combination of SRM. Most of dental follicle cell-derived NLCCs had a diameter of about 50-150 mm (Fig. 5) . In contrast to poly-L-lysine we detected only surface adherent cells on gelatin and laminin. Here, cells displayed relatively long axon-like cell extensions (Fig. 3) . On laminin/ poly-L-ornithine, DFCs differentiated into surface adherent cells in NSCM I and NSCM III (Fig. 3 ) and formed adherent NLCCs after 4 days and free-floating NLCCs after additional 7 days of treatment with NSCM II protocol (Fig. 3) . However, neural cell markers nestin and b-III-tubulin were constitutively expressed in NSCM II and NSCM III but differentially expressed in NSCM I (Fig. 4) . Interestingly, gene expression of NSE was differentially expressed in cells after the formation of NLCCs on poly-L-lysine and in NSCM II on laminin/poly-L-ornithine. For an evaluation of real-time RT-PCR data, a statistical test (multiple ANOVA, analysis of variance) was done. The dependence of neural cell marker expression on cell culture media and cell culture substrate demonstrated a peak neural differentiation on poly-L-lysine surface with use of cell culture medium NSCM I and high expression levels of NSE in NSCM II and NSCM III (Fig. 4) .
We made a real-time RT-PCR analysis (Table 1) for marker genes of neural subpopulations for a further categorization of differentiated cells . The expression of choline acetyltransferase characteristically for cholinergic neurons was detected neither before nor after differentiation of DFCs (data not shown). Calretinin (CALB2), a calcium-binding protein involved in calcium signaling, is often expressed in GABAergic neural cells. DFCs expressed CALB2 at all timepoints, but were not differentially affected by culture conditions (Table 1) . Parvalbumin (PVALB) is present in GABAergic interneurons of the nervous system and was expressed after cultivation in DMEM on poly-Llysine and after differentiation in NSCM II on laminin, but not expressed in naïve DFCs on polysterene. The neuropeptides galanin (GAL) and tachykinin (TAC1), the precursor of substance P, are small or small/intermediate neuron markers. DFCs in DMEM and polysterene expressed GAL and TAC1 at low levels. Gene expression of both markers was increased after differentiation in SRM, especially in NLCCs on poly-L-lysine and on laminin/poly-L-ornithine (Table 1) . Therefore NLCCs probably contain smalland intermediate-sized neurons or neural precursor cells. Interestingly, the large neuron marker vasoactive intestinal peptide (VIP) was also expressed weakly after differentiation with NSCM I and NSCM II (Table 1) . We found that tyrosine hydoxylase (TH), a marker of dopaminergic neurons, was detectable only in DFCs after cultivation in NSCM II and NSCM III on polysterene. However, this marker was expressed after cultivation on poly-L-lysine and gelatin. Glutamate decarboxylase 1 (GAD1), a marker of GABAergic neurons, was down-regulated or not differentially expressed after differentiation. In contrast, the gene of the neurotransmitter transporter serotonin (SLC6A4), a marker of serotonergic neurons, was differentially expressed after cultivation in SRM. To achieve more advanced neural differentiation we produced NLCCs in NSCM I and differentiated these cells with a protocol that was recently described for neural differentiation of dental pulp stem cells (Arthur et al., 2008) . After cultivation on poly-Lornithine and laminin NLCCs attached, spread and formed single cells with neuron-like morphologies (Fig. 6E-H) . These cells differentially expressed neuron cell markers such as neuronspecific enolase and neurofilament, which were weakly expressed in undifferentiated DFCs (Fig. 6A-D) . In contrast, early neural cell markers, nestin and b-III-tubulin, which were strongly expressed in naïve DFCs, were down-regulated after the second differentiation step. We detected by real-time RT-PCRs that gene expression of nestin, increased after the formation of NLCCs, and was down-regulated after a further differentiation step. Moreover, the early neuron-specific marker b-III-tubulin was constitutively expressed after the second step of differentiation. In contrast, gene expression of NSE and neurofilament was increased after differentiation (Fig. 6I) . Here, gene expression of NSE was remarkably increased after the second differentiation step on poly-L-ornithine and laminin. Gene markers for neural subpopulations demonstrated a differential expression of the neuropeptide TAC1 and the calcium-binding protein CALB2 (Fig. 6J) . By contrast, expression levels of SLC6A4, GAD1 and GAL were lower than in undifferentiated or pre-differentiated DFCs. All other tested marker genes of neural subpopulations were not expressed in differentiated DFCs. The astrocyte marker GFAP was not detected before and after differentiation (data not shown).
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Discussions
DFCs can differentiate into various cell types like cementoblasts, adipocytes or chondrocytes. However, less was known about neural differentiation potential of DFCs (Kemoun et al., 2007; Morsczeck et al., 2005a, b) . In our study naïve DFCs strongly expressed early neural cell markers and on a low level markers for mature neural cells Corti et al., 2003; Wachs et al., 2003; Widera et al., 2007) . The expression of cell markers can be identified in naïve DFCs by both immunocytochemistry and quantitative (real-time) RT-PCR. The real-time RT-PCR is the most sensitive technique for a quantitative analysis of gene expression (Peirson et al., 2003) . In our study, we were interested in also recording minor effects on neural differentiation after applying different cell culture conditions. Gene expression profiles of neural cell markers were therefore estimated by real-time RT-PCR after neural differentiation.
This study characterized human dental follicle cells after cultivation in three different SRMs, which comprise the B27 supplement or the G5 supplement for maintenance and differentiation of neural stem cells (Wachs et al., 2003) . The B27 supplement was frequently used for neural stem cell cultures and for neural differentiation of somatic stem cells (Engelhardt et al., 2004 (Engelhardt et al., , 2005 Miura et al., 2003; Wachs et al., 2003; Widera et al., 2007) . NSCM II was a two-step neural differentiation protocol adapted from a successful protocol for neural differentiation of mesenchymal stem cells (Hermann et al., 2004 (Hermann et al., , 2006 . Here, Storch and colleagues were able to transdifferentiate human mesenchymal stem cells into NLCCs and later into neural-like cells. In our study the formation of NLCCs was evident with NSCM II (day 11) in combination with the cell culture substrate laminin/poly-L-ornithine, but only the expression of NSE does support this tendency of neural differentiation. However, we also made use of a less-often utilized serum-free medium (NSCM I) composed of the G5-supplement and a specific neural stem cell supplement. The G5-supplement was originally designed for cell-growth and differentiation of glial cells and contains growth factors such as EGF and FGF (Michler-Stuke and Bottenstein, 1982) . Recently, it was also used for neural differentiation of mesenchymal stem cells (Hemptinne et al., 2004) . Interestingly, in our study this medium was the most favorable for a pre-differentiation of DFCs into neural precursor cells. For our study surface modifications were used that previously facilitated neural differentiation of stem cells. Gelatin-coated wells, for example, were successfully used for neural and glial cell differentiation of embryonic stem cell-derived neural progenitor cells (Goetz et al., 2006; Zhang et al., 2006) . In this study, gelatin does not improve neural differentiation of DFCs. For the differentiation of neural stem cells, cell culture dishes were often modified with laminin or a combination of laminin and polyornithine or poly-D-lysine (Engelhardt et al., 2004 (Engelhardt et al., , 2005 Ho et al., 2006; Widera et al., 2007) . We identified (as mentioned above) the formation of NLCCs from DFCs after cultivation on laminin/ poly-L-ornithine in combination with NSCM II. For mesenchymal stem cells, Ho et al. (2006) demonstrated that the induction of the neural stem cell marker, nestin, depends on a laminin substrate. In contrast, Storch and colleagues described the expression of nestin in naïve mesenchymal stem cells (Hermann et al., 2004; Hermann et al., 2006) . These experiments suggest that the expression of neural cell markers is also strongly dependent on cell isolation procedures and the quality of donor tissues. For neural differentiation Storch and colleagues successfully applied poly-L-lysine for the neural differentiation of mesenchymal stem cells (Hermann et al., 2004 (Hermann et al., , 2006 . In correspondence to this examination we found that poly-L-lysine is the most favorable surface modification for the formation of NLCCs and an increased expression of neural cell markers, especially early markers such as b-III-tubulin. In this context, it is remarkable that the expression of the neural progenitor cell marker, nestin, was significantly up-regulated (po0.05; n ¼ 3; Student's t-test, statistics not shown in Fig. 4 ) after cultivation on poly-L-lysine in regular cell culture medium in comparison to each other tested cell culture surface. Interestingly the formation of NLCCs and the up-regulation of the neural cell marker NSE correlate very well in this study.
To obtain differentiated DFCs with typical neural cell morphology a second step of neural differentiation was required. In contrast to naïve DFCs, these cells strongly express neurofilament. However, neural differentiation of DFCs was not possible without a pre-differentiation step. Neural differentiated DFCs differentially express the neuropeptide, TAC1, which is thought to function as a neurotransmitter which interacts with nerve receptors and smooth muscle cells. Interestingly, TAC1 was also identified in neural differentiated mesenchymal stem cells . Fig. 3 . Light microscope images displaying DFCs after cultivation in SRM. Cells were cultivated in regular cell culture media with serum (DMEM), NSCM I and NSCM III for 7 days on different surface modifications. For cultivation in NSCM II DFCs were pre-differentiated in Neurobasal-medium with B27 supplement, 20 ng/ml EGF and 20 ng/ml FGF-2 without retinoic acid for 4 days (NSCM II day 4). Here, cells formed surface adherent NLCCs. These pre-treated DFCs were then cultivated without growth factors but with retinoic acid for additional 7 days (NSCM II day 11). DFCs formed NLCCs on poly-L-lysine in NSCM I, NSCM II and NSCM III and on poly-L-ornithine/laminin in NSCM II. DFCs were surface adherent and had fibroblastic cell morphology in DMEM. In contrast to DMEM single DFCs became neural-like cells after cultivation in NSCM I, NSCM II and NSCM III on gelatin, laminin and polystyrene. Similar morphologies were observed on laminin/poly-L-ornithine in NSCM I and NSCM III.
ARTICLE IN PRESS
Our study investigated neural differentiation of human DFCs for the first time. We demonstrated that naïve DFCs express early neural cell markers. In our study, naïve and differentiated DFCs did not express the glial cell marker GFAP. We conclude that DFCs are neural precursor without potential for glial cell differentiation. Further investigation will determine whether the expression of glial cell markers depends on appropriate cell culture conditions. DFCs differentiate into cells at an early stage of neural differentiation that was demonstrated by an upregulation of early neural cell markers and by the formation of NLCCs. After a second step of differentiation, late neural cell markers, NSE and neurofilament were up-regulated. We conclude that DFCs displayed characteristics of neural progenitor cells and they are a promising alternative for new cell therapy approaches. 
